These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4427121)

  • 1. Serum immunoglobulins in epilepsy.
    Slavin BN; Fenton GM; Laundy M; Reynolds EH
    J Neurol Sci; 1974 Nov; 23(3):353-7. PubMed ID: 4427121
    [No Abstract]   [Full Text] [Related]  

  • 2. Folate therapy in epilepsy. A controlled study.
    Mattson RH; Gallagher BB; Reynolds EH; Glass D
    Arch Neurol; 1973 Aug; 29(2):78-81. PubMed ID: 4577819
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of epilepsy in the light of determinations of the blood levels of anticonvulsants.
    Majkowski J
    Pol Med J; 1972; 11(1):202-7. PubMed ID: 5040998
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of antiepileptic blood levels in the treatment of patients with epilepsy.
    Fincham RW; Schottelius DD
    J Iowa Med Soc; 1973 Sep; 63(9):433-6. PubMed ID: 4742131
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
    Watanabe S; Kuyama C; Yokoyama S; Kubo S; Iwai H
    Folia Psychiatr Neurol Jpn; 1977; 31(2):205-17. PubMed ID: 903037
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy.
    Aarli JA
    Acta Neurol Scand; 1976 Nov; 54(5):423-30. PubMed ID: 998166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 8. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between dose and serum concentrations of carbamazepine, phenytoin, phenobarbital, and primidone in a Sri Lankan population compared with a European population.
    Peiris JB; Karunanayake EH; Joice PD; Goedhart DM; Meijer JW; Meinardi H
    Epilepsia; 1988; 29(5):564-70. PubMed ID: 3409842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primidone, diphenylhydantoin and phenobarbital. Aspects of acute and chronic toxicity.
    Gallagher BB; Baumel IP; Mattson RH; Woodbury SG
    Neurology; 1973 Feb; 23(2):145-9. PubMed ID: 4734509
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Special viewpoints in the treatment with anticonvulsants in childhood. Value of determination of serum level of anticonvulsants in the treatment of seizures].
    Windorfer A
    Fortschr Med; 1974 Oct; 92(28):1102-4. PubMed ID: 4457423
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoglobulins in epilepsy.
    Bassanini M; Baez A; Sotelo J
    J Neurol Sci; 1982 Nov; 56(2-3):275-81. PubMed ID: 7175551
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.
    Callaghan N; Feely M; Duggan F; O'Callaghan M; Seldrup J
    Acta Neurol Scand; 1977 Jul; 56(1):1-6. PubMed ID: 878841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between serum and cerebrospinal fluid anticonvulsant drug and folic acid concentrations in epileptic patients.
    Reynolds EH; Mattson RH; Gallagher BB
    Neurology; 1972 Aug; 22(8):841-4. PubMed ID: 4673411
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the serum immunoglobulins levels induced by phenytoin in epileptic children].
    Talesnik E; Rivero S; González B
    Rev Chil Pediatr; 1985; 56(2):76-80. PubMed ID: 4089271
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug.
    Windorfer A; Sauer W; Gädeke R
    Acta Paediatr Scand; 1975 Sep; 64(5):771-2. PubMed ID: 1101639
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum levels of anticonvulsants and haematological sequelae in black epileptics.
    Buchanan N; Bill P; Strickwold B; Eyberg C; Moodley GP; Fernandes Costa F
    S Afr Med J; 1977 Apr; 51(15):504-8. PubMed ID: 857325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anti-convulsant drugs.
    Braide SA; Davies TJ
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():391-9. PubMed ID: 2889417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in response to anticonvulsants in a group of epileptic patients.
    Travers RD; Gallagher BB; Glaser GH
    Trans Am Neurol Assoc; 1971; 96():110-2. PubMed ID: 5159062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.